Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DentaMedica is a comprehensive dental recovery support dietary supplement developed by StellaLife. It is formulated with a combination of vitamin D3, vitamin K2, vitamin A, B-complex vitamins, beta-carotene, and various essential minerals. The supplement is specifically designed to optimize nutrient levels in patients undergoing dental procedures, such as dental implant surgery, to promote bone and soft tissue healing. By targeting the vitamin D pathway and activating the vitamin D receptor (VDR), DentaMedica addresses vitamin D deficiency, which research has linked to significantly higher rates of early dental implant failure. It is administered orally as capsules and is available in 6-week or 12-week supply kits for surgical recovery, or as a daily multivitamin for maintenance of dental and overall health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DentaMedica.